<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-2127BTNT</identifier><date>1997</date><creator>Eržen, Janez</creator><relation>documents/doc/2/URN_NBN_SI_doc-2127BTNT_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2127BTNT_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 29-35</format><identifier identifier_type="COBISSID_HOST">7731417</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2127BTNT</identifier><language>slv</language><publisher>Glaxo Wellcome</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Diagnosis</subject><subject language_type_id="eng">Esophageal neoplasms</subject><subject language_type_id="eng">Therapy</subject><title>Rak požiralnika</title></Record>